Darzine Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.50 M
as on 25-12-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -49.92%
(FY 2017)
- Profit 11.37%
(FY 2017)
- Ebitda 61.16%
(FY 2017)
- Net Worth 1.16%
(FY 2017)
- Total Assets -29.88%
(FY 2017)
About Darzine Remedies
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ayush Srivastava, Munni Singh, Dileep Singh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85191UP2011PTC046882
- Company No.
046882
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Darzine Remedies Private Limited offer?
Darzine Remedies Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Brain & Nervous System Drugs, Psychotherapeutic Agents, Antidepressant & Anti Anxiety Medicines, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Multivitamin Tablets & Capsules, Iron Folic Acid Tablet, Dietary Supplements.
Who are the key members and board of directors at Darzine Remedies?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayush Srivastava  | Director | 12-Aug-2022 | Current |
| Munni Singh | Director | 24-Apr-2019 | Current |
| Dileep Singh | Director | 07-Oct-2011 | Current |
| Ramesh Singh | Director | 07-Oct-2011 | Current |
| Vandana Srivastav | Director | 10-Apr-2024 | Current |
Financial Performance of Darzine Remedies.
Darzine Remedies Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 49.92% decrease. The company also saw a substantial improvement in profitability, with a 11.37% increase in profit. The company's net worth moved up by a moderate rise of 1.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Darzine Remedies?
In 2017, Darzine Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Darzine Remedies?
Unlock and access historical data on people associated with Darzine Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Darzine Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darzine Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
